Abstract
The present project aims to develop a device for diagnosing and monitoring brain cancer (gliomas) in a minimally invasive way, through biomarkers (exosomes) present in the blood. The future device developed can be used in the clinical scenario (in situ), significantly renewing the entire field of medical oncology, in addition to being highly attractive due to its low cost and speed of ope…